U.K. Adjusts Drug Pricing Strategies to Mitigate U.S. Tariffs
UK Secures Agreement to Enhance Drug Pricing, Navigates US Tariffs, and Transforms Pharmaceutical Landscape The United Kingdom has successfully negotiated a strategic agreement aimed at increasing drug prices while circumventing U.S. tariffs. This pivotal deal is set to reshape the pharmaceutical industry, influencing pricing strategies and market dynamics.